Pierre Blanchard, Editor in Chief of Radiotherapy and Oncology, aka Green Journal, Radiation Oncologist at Gustave Roussy, shared a post on X:
“Another proof that metastasis directed therapy improves outcomes, this time in castration resistant prostate cancer.
Congrats to the PCS IX team!”
Title: Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial
Authors: Tamim Niazi, Fred Saad, Steven Tisseverasinghe, Rashmi Koul, Isabelle Thibault, Peter W M Chung, George Wakil, Michael Lock, Guila Delouya, Boris Bahoric, Andrew Feifer, Venkata Ramana Agnihotram, Theodoros Tsakiridis, Fabio L Cury, Rafika Dahmane, Nikhilesh Gajanan Patil, Scott Tyldesley
Read The Full Article at The Lancet Oncology.
More posts featuring Pierre Blanchard.